This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Scott Arne Johnson: Innovator in Hemoglobinopathy Treatment
Introduction
Scott Arne Johnson is a notable inventor based in San Diego, California. He has made significant contributions to the field of medicine, particularly in the treatment of hemoglobinopathies. His innovative work has led to the development of compounds that offer new methods for prevention and treatment.
Latest Patents
Scott Arne Johnson holds a patent for "Compounds and their use for treatment of hemoglobinopathies." This patent discloses various compounds and methods aimed at preventing and treating hemoglobinopathies. Additionally, it includes pharmaceutical compositions that utilize these compounds for effective treatment.
Career Highlights
Johnson is associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work at this esteemed organization has allowed him to focus on groundbreaking research and development in the medical field.
Collaborations
Some of his notable coworkers include Thomas J. Cummins and Hannah L. Powers. Their collaborative efforts contribute to the advancement of innovative treatments in the pharmaceutical industry.
Conclusion
Scott Arne Johnson's contributions to the treatment of hemoglobinopathies through his patented compounds highlight his role as an influential inventor in the medical field. His work continues to pave the way for advancements in healthcare.